What does Apotheek Werchter do?

Apotheek Werchter is a pharmacy in Rotselaar. Public Limited, started on 22 December 2010, 1 establishment.

What is the address of Apotheek Werchter?

The registered office of Apotheek Werchter is located at Tweebruggenstraat 7, 3118 Rotselaar.

Is Apotheek Werchter still active?

Yes. According to the CBE (30 October 2026) Apotheek Werchter is active, legal situation “Normale toestand”, started on 22 December 2010.

Is Apotheek Werchter registered on Peppol?

Yes, Apotheek Werchter is registered on the Peppol network with ID 0208:0832197543.

What is the enterprise number of Apotheek Werchter?

The enterprise number of Apotheek Werchter is BE0832197543.

When was Apotheek Werchter founded?

Apotheek Werchter was founded on 22 December 2010.

Who are the directors of Apotheek Werchter?

According to the 2025 annual accounts, the directors of Apotheek Werchter are: FARMALIEN BV, PHARMA - GODFROID BV.

Is Apotheek Werchter a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2010; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Apotheek Werchter make in 2025?

Apotheek Werchter posted a profit after taxes of € 31,864 in financial year 2025.

What is the revenue of Apotheek Werchter?

As a small company, Apotheek Werchter is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 129,592.

How much does an employee at Apotheek Werchter earn?

The average wage cost per full-time employee at Apotheek Werchter was € 82,300 in 2025: staff costs of € 82,292 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Werchter have?

According to the 2025 annual accounts, Apotheek Werchter has 1 full-time equivalents (FTE).

Does Apotheek Werchter have a website?

Yes, Apotheek Werchter has a website at apotheekwerchter.be.

Apotheek Werchter (Public Limited) - Rotselaar

Dossier Apotheek Werchter, printed on 30 October 2026 from databakkes.be/en/0832197543/apotheek-werchter. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 1.7 to 1.

Financials

Financial year 2025

Apotheek Werchter from Rotselaar, company number BE0832197543, closed financial year 2025 with a result of € 31,864 after tax. For that financial year Apotheek Werchter recorded a gross margin of € 129,592 and equity of € 210,710. Compared with financial year 2024, the result moved from € 4,291 to € 31,864. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.

What it is worth Growing

€ 210,710

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 31,864

▲ € 27,573 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 84,714

▲ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 31,000 paid out

97 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 82,292

▲ 13% vs 2024

€ 82,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 89,528

▼ 8% vs 2024

€ 8,230 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 53,048

▼ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,655

▲ 28% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 113,494 Gross margin 2022: € 113,494 First fiscal year in the series	€ 88,711 Gross margin 2023: € 88,711 ▼ 22% vs 2022 (€ 113,494) Unfavourable step	€ 87,494 Gross margin 2024: € 87,494 ▼ 1% vs 2023 (€ 88,711) Unfavourable step	€ 129,592 Gross margin 2025: € 129,592 ▲ 48% vs 2024 (€ 87,494) Favourable step	▲ 48%
Profit after taxes	€ 40,410 Profit after taxes 2022: € 40,410 First fiscal year in the series	€ -16,060 Profit after taxes 2023: € -16,060 ▼ € 56,471 vs 2022 (€ 40,410) Unfavourable step	€ 4,291 Profit after taxes 2024: € 4,291 ▲ € 20,352 vs 2023 (€ -16,060) Favourable step	€ 31,864 Profit after taxes 2025: € 31,864 ▲ € 27,573 vs 2024 (€ 4,291) Favourable step	▲ € 27,573
Equity	€ 221,614 Equity 2022: € 221,614 First fiscal year in the series	€ 205,554 Equity 2023: € 205,554 ▼ 7% vs 2022 (€ 221,614) Unfavourable step	€ 209,845 Equity 2024: € 209,845 ▲ 2% vs 2023 (€ 205,554) Favourable step	€ 210,710 Equity 2025: € 210,710 Unchanged (€ 209,845) Favourable step
Total debts	€ 264,558 Total debts 2022: € 264,558 First fiscal year in the series	€ 146,769 Total debts 2023: € 146,769 ▼ 45% vs 2022 (€ 264,558) Favourable step	€ 190,207 Total debts 2024: € 190,207 ▲ 30% vs 2023 (€ 146,769) Unfavourable step	€ 192,062 Total debts 2025: € 192,062 ▲ 1% vs 2024 (€ 190,207) Unfavourable step	▲ 1%
Cash	€ 55,034 Cash 2022: € 55,034 First fiscal year in the series	€ 29,925 Cash 2023: € 29,925 ▼ 46% vs 2022 (€ 55,034) Unfavourable step	€ 70,519 Cash 2024: € 70,519 ▲ 136% vs 2023 (€ 29,925) Favourable step	€ 84,714 Cash 2025: € 84,714 ▲ 20% vs 2024 (€ 70,519) Favourable step	▲ 20%
Retained profit	€ 160,114 Retained profit 2022: € 160,114 First fiscal year in the series	€ 144,054 Retained profit 2023: € 144,054 ▼ 10% vs 2022 (€ 160,114) Unfavourable step	€ 148,345 Retained profit 2024: € 148,345 ▲ 3% vs 2023 (€ 144,054) Favourable step	€ 149,210 Retained profit 2025: € 149,210 ▲ 1% vs 2024 (€ 148,345) Favourable step	▲ 1%
Dividend	€ 60,000 Dividend 2022: € 60,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 60,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 31,000 Dividend 2025: € 31,000 Unchanged (€ 0) Unchanged
Bank debt	€ 38,108 Bank debt 2022: € 38,108 First fiscal year in the series	€ 55,429 Bank debt 2023: € 55,429 ▲ 45% vs 2022 (€ 38,108) Unfavourable step	€ 97,570 Bank debt 2024: € 97,570 ▲ 76% vs 2023 (€ 55,429) Unfavourable step	€ 89,528 Bank debt 2025: € 89,528 ▼ 8% vs 2024 (€ 97,570) Favourable step	▼ 8%
Balance sheet total	€ 486,172 Balance sheet total 2022: € 486,172 First fiscal year in the series	€ 352,323 Balance sheet total 2023: € 352,323 ▼ 28% vs 2022 (€ 486,172) Unchanged	€ 400,053 Balance sheet total 2024: € 400,053 ▲ 14% vs 2023 (€ 352,323) Unchanged	€ 402,771 Balance sheet total 2025: € 402,771 ▲ 1% vs 2024 (€ 400,053) Unchanged	▲ 1%
Employees (FTE)	1.5 Employees (FTE) 2022: 1.5 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 ▲ 0.2 vs 2022 (1.5) Unchanged	1.1 Employees (FTE) 2024: 1.1 ▼ 0.6 vs 2023 (1.7) Unchanged	1 Employees (FTE) 2025: 1 ▼ 0.1 vs 2024 (1.1) Unchanged	▼ 0.1

Key figures of Apotheek Werchter, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Werchter?

What happened at Apotheek Werchter in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 FARMALIEN BV stepped down as director. NBB
2027 PHARMA - GODFROID BV stepped down as director. NBB
Jul 14, 2026 New annual accounts for financial year 2025: profit of € 31,864 (▲ € 27,573 vs 2024). Source: NBB ↗
2021 FARMALIEN BV became a director. NBB
2021 PHARMA - GODFROID BV became a director. NBB
Dec 22, 2010 New establishment in Rotselaar. KBO
Dec 22, 2010 Start of the company according to the CBE. KBO

In short

From € 40,410 profit in 2022 to € 31,864 profit in 2025.

Paid € 3,260 in corporate taxes since 2022.

Best year ever: 2022, with € 40,410 profit.

On average € 129,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

FARMALIEN 49.9%

Pharma-Godfroid 49.9%

The stake of FARMALIEN, Pharma-Godfroid comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Werchter

The shares are held by FARMALIEN (49.9%) and Pharma-Godfroid (49.9%).

Directors

According to the 2025 annual accounts

FARMALIEN BV

Director · represented by Dupont Elien

since 2021 · until 2027

PHARMA - GODFROID BV

Director · represented by Godfroid Laurence

since 2021 · until 2027

Shareholders

FARMALIEN

49.9%

Pharma-Godfroid

49.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Tweebruggenstraat 7

3118 Rotselaar

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekwerchter.be

Canonical: https://www.apotheekwerchter.be/

Technologies

Anime.jsElementorFont AwesomeGoogle AnalyticsGoogle FontsLiteSpeedPHPWooCommerceWordPressYouTube EmbedjQueryjQuery UIlazysizes

Hosting & Email

Email provider

Self-hosted

Hosting

NAMEHERO-KCDC - Name Hero, LLC, US

Domain

apotheekwerchter.be

Registered

2015-10-07

Website info

HTTPS Ja

Languages EN

Features

Webshop Newsletter

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number: 0832.197.543
VAT number: BE 0832.197.543
Registered office: Tweebruggenstraat 7, 3118 Rotselaar
Names & denominations: Apotheek Werchter
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 22 December 2010
Peppol: Active · Active since 29 Sept 2025
Contact: apotheekwerchter.be
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗